Search
Menu
Alluxa - Optical Coatings LB 8/23

CardioGenesis Closes Private Placement With Wisconsin Investment Board

Facebook X LinkedIn Email
FOOTHILL RANCH, Calif., Dec. 28 -- CardioGenesis Corp. has announced the closing of a $2.0 million private placement of its common stock with the State of Wisconsin Investment Board. The private placement involved 2,222,225 shares of CardioGenesis common stock at a fixed price and terms agreed in mid-December.

CardioGenesis is a medical device company specializing in the treatment of cardiovascular disease and is the leader in products that stimulate cardiac angiogenesis. The company's Holmium:YAG laser system and disposable fiber optic accessories are used to perform an FDA-cleared surgical procedure known as transmyocardial revascularization to treat patients suffering from angina.

Ohara Corp. - Optical Glass, Polish substrates 10-23

Published: December 2001
News & Features

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.